(1)
Zhou, S.; Deng, M.; Bian, X.; Shi, J.; Liang, R.; Tao, M. Synergistic Anti-Tumor Effects of Lenalidomide and Gefitinib by Upregulating ADRB2 and Inactivating the mTOR/PI3K/AKT Signaling Pathway in Lung Adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD. Cell Mol Biol (Noisy-le-grand) 2024, 70, 120-127.